NCT00424099

Methylphenidate and a Nursing Telephone Intervention for Fatigue

190 people

67.4%

32.6%

128 womenmiddle line = equal numbers62 men

Phase: PHASE2, PHASE3
Paid for by: M.D. Anderson Cancer Center
Finished: 2021-11-22
Health conditions: Advanced Cancer, Fatigue
Who could join: Anyone
Ages: 18 Years – no maximum
Average age: median 57.5 years
Age 65+: Not reported
Weight (BMI): Not reported
Pregnancy recorded: Not reported
Menopause recorded: Not reported
Results shown by sex: Not split by sex
Race: White 88.9% · Black / African American 10% · Asian 1.1% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · More than one race 0% · Not reported 0%

No pregnant women
Women who were pregnant could not join.
“Pregnant or lactating women”
No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant or lactating women”
No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Major contraindication to methylphenidate i.e. hypersensitivity, anxiety, tension, agitation, or motor tics, glaucoma, severe angina pectoris, or hypertension, etc.”
No seizures
Women with epilepsy or past seizures were turned away.
“Currently receiving oral anticoagulants (Coumadin/warfarin), anticonvulsants (Phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).”
No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Major depression according to the Structured Clinical Interview (SCID) Diagnostic and Statistical Manual of Mental Disorders (DSM) IV diagnostic criteria. These patients wil be referred immediately to psychiatry for assessment and managemen…”

Study titles and rules are shown in their original English.